vimarsana.com
Home
Live Updates
Marvel Biosciences Announces Positive Interim Results for Autism Treatment with MB-204 : comparemela.com
Marvel Biosciences Announces Positive Interim Results for Autism Treatment with MB-204
Marvel Biosciences Corp. , and its wholly owned subsidiary, Marvel Biotechnology Inc. , today reported promising interim results from its study on MB-204, a new treatment for autism, conducted by the...
Related Keywords
France ,
Jerome Becker ,
Mark Williams ,
Julie Le Merrer ,
Marvel Biotechnology Inc ,
Marvel Biosciences Corp ,
Venture Exchange ,
Regulation Services Provider ,
Alberta Newsfile Corp ,
Company Or Marvel ,
Marvel Biotechnology ,
Brain Institute ,
Biosciences Corp ,
Chief Executive Officer ,
Chief Science ,
comparemela.com © 2020. All Rights Reserved.